Breaking News Instant updates and real-time market news.

SBRA

Sabra Health Care

$13.80 /

+0.24 (+1.77%)

09:04
09/25/20
09/25
09:04
09/25/20
09:04

Sabra Health Care provides update regarding rental revenues recognition

Sabra Health Care provided an update regarding its recognition of rental revenues under leases with Genesis Healthcare, and Signature Healthcare in light of recent events. The company said, "In the Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 that Genesis filed with the Securities and Exchange Commission on August 10, 2020, Genesis stated that the impact of COVID-19 on its future results of operations, its current financial condition and liquidity sources, and uncertainty regarding future governmental funding support raises substantial doubt about its ability to continue as a going concern. On September 11, 2020, we learned that subsidiaries of Signature that lease facilities from the Company will be issued an audit report containing a qualified opinion due to substantial doubt about their ability to continue as a going concern in relation to the uncertainty around future cashflows caused by the COVID-19 pandemic. To date, Sabra has received no rent relief requests from either Genesis or Signature and both tenants remain current on their rental obligations. As of June 30, 2020, our exposure to Signature was 7.2% of Sabra's annualized cash NOI and our exposure to Genesis was 2.5% of Sabra's annualized cash NOI exclusive of residual rents from previously completed sales representing 2.0% of Sabra's annualized cash NOI. Sabra and its auditors are evaluating the circumstances giving rise to the going concern issues for these tenants as it relates to the proper accounting under GAAP, including the potential need to transition the method of recognizing rental revenue generated by leases with these two tenants from accrual basis accounting, with straight-line rental receivable, to cash-basis accounting. In the event we transition the leases with these tenants to cash-basis accounting, we would write-off approximately $14.4 million of straight-line rental receivables and lease-related intangible assets, which would be recorded as a reduction to rental revenues but would have no impact on Normalized FFO, AFFO, Normalized AFFO and distributable cash flow; if this change were to occur, we expect rental revenues to initially increase by an immaterial amount. We expect to complete this evaluation during our third quarter reporting cycle."

SBRA Sabra Health Care
$13.80 /

+0.24 (+1.77%)

09/01/20 Stifel
Sabra Health Care resumed with a Hold at Stifel
07/02/20 Citi
Sabra Health Care price target raised to $14 from $10 at Citi
06/23/20 Scotiabank
Sabra Health Care upgraded to Sector Perform with $15 target at Scotiabank
06/23/20 Scotiabank
Sabra Health Care upgraded to Sector Perform from Underperform at Scotiabank

TODAY'S FREE FLY STORIES

Recommendations
Yara price target lowered to NOK 400 from NOK 420 at UBS » 11:46
10/21/20
10/21
11:46
10/21/20
11:46
YARIY

Yara

$0.00 /

+ (+0.00%)

UBS analyst Andrew Stott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YARIY Yara
$0.00 /

+ (+0.00%)

06:29 Today Credit Suisse
Yara downgraded to Neutral from Outperform at Credit Suisse
09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Morgan Stanley
Yara downgraded to Equal Weight from Overweight at Morgan Stanley
07/21/20 Berenberg
Yara price target raised to NOK 420 from NOK 415 at Berenberg
Recommendations
Vifor Pharma price target lowered to CHF 129 from CHF 142 at UBS » 11:46
10/21/20
10/21
11:46
10/21/20
11:46
GNHAF

Vifor Pharma

$0.00 /

+ (+0.00%)

UBS analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNHAF Vifor Pharma
$0.00 /

+ (+0.00%)

GNHAF Vifor Pharma
$0.00 /

+ (+0.00%)

09/04/20 Stifel
Vifor Pharma price target lowered to CHF 158 from CHF 160 at Stifel
09/02/20 Barclays
Vifor Pharma price target lowered to CHF 140 from CHF 155 at Barclays
08/26/20 Deutsche Bank
Vifor Pharma price target lowered to CHF 150 from CHF 160 at Deutsche Bank
08/13/20 UBS
Vifor Pharma price target lowered to CHF 142 from CHF 149 at UBS
Recommendations
Volvo AB price target raised to SEK 184 from SEK 176 at UBS » 11:46
10/21/20
10/21
11:46
10/21/20
11:46
VLVLY

Volvo AB

$0.00 /

+ (+0.00%)

UBS analyst Guillermo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLVLY Volvo AB
$0.00 /

+ (+0.00%)

VLVLY Volvo AB
$0.00 /

+ (+0.00%)

10/19/20 Societe Generale
Volvo AB upgraded to Hold from Sell at Societe Generale
10/19/20 Societe Generale
Volvo AB upgraded to Hold from Sell at Societe Generale
10/19/20 JPMorgan
Volvo AB price target raised to SEK 225 from SEK 210 at JPMorgan
10/19/20 RBC Capital
Volvo AB price target raised to SEK 173 from SEK 155 at RBC Capital
VLVLY Volvo AB
$0.00 /

+ (+0.00%)

Recommendations
Vivendi price target raised to EUR 33 from EUR 32 at UBS » 11:45
10/21/20
10/21
11:45
10/21/20
11:45
VIVHY

Vivendi

$0.00 /

+ (+0.00%)

UBS analyst Richard Eary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIVHY Vivendi
$0.00 /

+ (+0.00%)

VIVHY Vivendi
$0.00 /

+ (+0.00%)

10/20/20 Deutsche Bank
Vivendi price target lowered to EUR 29 from EUR 37 at Deutsche Bank
10/13/20 Morgan Stanley
Vivendi price target raised to EUR 34 from EUR 31 at Morgan Stanley
07/15/20 UBS
Vivendi price target raised to EUR 32 from EUR 30 at UBS
07/08/20 Bernstein
Vivendi initiated with an Outperform at Bernstein
VIVHY Vivendi
$0.00 /

+ (+0.00%)

VIVHY Vivendi
$0.00 /

+ (+0.00%)

VIVHY Vivendi
$0.00 /

+ (+0.00%)

Recommendations
Swedbank price target raised to SEK 175 from SEK 172 at UBS » 11:45
10/21/20
10/21
11:45
10/21/20
11:45
SWDBY

Swedbank

$0.00 /

+ (+0.00%)

UBS analyst Johan Ekblom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWDBY Swedbank
$0.00 /

+ (+0.00%)

11:41 Today Morgan Stanley
Swedbank price target raised to SEK 176 from SEK 165 at Morgan Stanley
11:21 Today Deutsche Bank
Swedbank price target raised to SEK 168 from SEK 165 at Deutsche Bank
11:13 Today Societe Generale
Swedbank price target raised to SEK 172 from SEK 165 at Societe Generale
10/19/20 Credit Suisse
Swedbank initiated with a Neutral at Credit Suisse
General news
San Francisco Federal Reserve Bank President Mary Daly Speech to be released at 12:00  11:45
10/21/20
10/21
11:45
10/21/20
11:45
 
General news
Minneapolis Federal Reserve Bank President Neel Kashkari Speech to be released at 12:00  11:45
10/21/20
10/21
11:45
10/21/20
11:45
 
General news
Dallas Federal Reserve Bank President Robert Kaplan Speech to be released at 12:00  11:45
10/21/20
10/21
11:45
10/21/20
11:45
 
Recommendations
Reckitt Benckiser price target raised to 8,750 GBp from 8,600 GBp at UBS » 11:44
10/21/20
10/21
11:44
10/21/20
11:44
RBGLY

Reckitt Benckiser

$0.00 /

+ (+0.00%)

UBS analyst Guillaume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

11:17 Today Societe Generale
Reckitt Benckiser price target raised to 6,800 GBp at Societe Generale
10/12/20 Bernstein
Reckitt Benckiser initiated with an Underperform at Bernstein
09/30/20 Barclays
Reckitt Benckiser price target lowered to 9,200 GBp from 9,400 GBp at Barclays
09/03/20 Deutsche Bank
Reckitt Benckiser price target lowered to 8,150 GBp at Deutsche Bank
RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

Recommendations
Logitech price target raised to CHF 74 from CHF 68 at UBS » 11:44
10/21/20
10/21
11:44
10/21/20
11:44
LOGI

Logitech

$92.71 /

+0.08 (+0.09%)

UBS analyst Joern Iffert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOGI Logitech
$92.71 /

+0.08 (+0.09%)

LOGI Logitech
$92.71 /

+0.08 (+0.09%)

08:21 Today DA Davidson
Logitech price target raised to $116 from $83 at DA Davidson
07:31 Today Wedbush
Logitech price target raised to $95 from $73.50 at Wedbush
07:26 Today Loop Capital
Logitech price target raised to $112 from $81 at Loop Capital
06:24 Today Citi
Logitech price target raised to $105 from $81 at Citi
LOGI Logitech
$92.71 /

+0.08 (+0.09%)

LOGI Logitech
$92.71 /

+0.08 (+0.09%)

LOGI Logitech
$92.71 /

+0.08 (+0.09%)

LOGI Logitech
$92.71 /

+0.08 (+0.09%)

Recommendations
Britvic price target raised to 900 GBp from 880 GBp at UBS » 11:43
10/21/20
10/21
11:43
10/21/20
11:43
BTVCY

Britvic

$0.00 /

+ (+0.00%)

UBS analyst Nik Oliver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTVCY Britvic
$0.00 /

+ (+0.00%)

11:16 Today Societe Generale
Britvic price target lowered to 930 GBp from 945 GBp at Societe Generale
09/30/20 Goldman Sachs
Britvic downgraded to Neutral from Buy at Goldman Sachs
09/23/20 JPMorgan
Britvic price target raised to 900 GBp from 850 GBp at JPMorgan
09/22/20 Morgan Stanley
Britvic initiated with an Overweight at Morgan Stanley
Recommendations
Tele2 price target lowered to SEK 155 from SEK 165 at Morgan Stanley » 11:43
10/21/20
10/21
11:43
10/21/20
11:43
TLTZY

Tele2

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TLTZY Tele2
$0.00 /

+ (+0.00%)

10/19/20 JPMorgan
Tele2 price target lowered to SEK 161 from SEK 163 at JPMorgan
08/20/20 JPMorgan
Tele2 price target raised to SEK 163 from SEK 155 at JPMorgan
07/22/20 Credit Suisse
Tele2 price target raised to SEK 162 from SEK 158 at Credit Suisse
06/11/20 Berenberg
Tele2 upgraded to Buy from Hold at Berenberg
Recommendations
Bouygues price target lowered to EUR 42 from EUR 43 at Morgan Stanley » 11:42
10/21/20
10/21
11:42
10/21/20
11:42
BOUYF

Bouygues

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOUYF Bouygues
$0.00 /

+ (+0.00%)

10/14/20 JPMorgan
Bouygues price target raised to EUR 41 from EUR 37 at JPMorgan
10/14/20 Barclays
Bouygues price target lowered to EUR 35.50 from EUR 36 at Barclays
09/17/20 Morgan Stanley
Bouygues price target raised to EUR 43 from EUR 41 at Morgan Stanley
09/10/20 Barclays
Bouygues downgraded to Equal Weight from Overweight at Barclays
Recommendations
Bayer price target lowered to EUR 68 from EUR 82 at Morgan Stanley » 11:42
10/21/20
10/21
11:42
10/21/20
11:42
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
10/02/20 Deutsche Bank
Bayer price target lowered to EUR 64 from EUR 82 at Deutsche Bank
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Recommendations
UBS price target raised to CHF 13 from CHF 12 at Morgan Stanley » 11:41
10/21/20
10/21
11:41
10/21/20
11:41
UBS

UBS

$12.36 /

-0.01 (-0.08%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$12.36 /

-0.01 (-0.08%)

UBS UBS
$12.36 /

-0.01 (-0.08%)

10/19/20 Barclays
UBS price target raised to CHF 10 from CHF 9.50 at Barclays
07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/23/20 Oddo BHF
UBS upgraded to Neutral from Reduce at Oddo BHF
07/22/20 Credit Suisse
UBS price target raised to CHF 14.50 from CHF 14 at Credit Suisse
UBS UBS
$12.36 /

-0.01 (-0.08%)

UBS UBS
$12.36 /

-0.01 (-0.08%)

UBS UBS
$12.36 /

-0.01 (-0.08%)

Downgrade
Janus Henderson Group downgraded to Equal Weight from Overweight at Morgan Stanley » 11:41
10/21/20
10/21
11:41
10/21/20
11:41
JHG

Janus Henderson Group

$27.16 /

-0.43 (-1.56%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JHG Janus Henderson Group
$27.16 /

-0.43 (-1.56%)

JHG Janus Henderson Group
$27.16 /

-0.43 (-1.56%)

10/12/20 Gordon Haskett
Voya Financial CEO 'fits the profile of a seller,' says Gordon Haskett
10/08/20 Credit Suisse
Janus Henderson Group upgraded to Neutral from Underperform at Credit Suisse
05/01/20 Goldman Sachs
Janus Henderson Group upgraded to Neutral from Sell at Goldman Sachs
04/30/20 Keefe Bruyette
Janus Henderson upgraded to Market Perform from Underperform at Keefe Bruyette
JHG Janus Henderson Group
$27.16 /

-0.43 (-1.56%)

JHG Janus Henderson Group
$27.16 /

-0.43 (-1.56%)

JHG Janus Henderson Group
$27.16 /

-0.43 (-1.56%)

Recommendations
Swedbank price target raised to SEK 176 from SEK 165 at Morgan Stanley » 11:41
10/21/20
10/21
11:41
10/21/20
11:41
SWDBY

Swedbank

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWDBY Swedbank
$0.00 /

+ (+0.00%)

11:21 Today Deutsche Bank
Swedbank price target raised to SEK 168 from SEK 165 at Deutsche Bank
11:13 Today Societe Generale
Swedbank price target raised to SEK 172 from SEK 165 at Societe Generale
10/19/20 Credit Suisse
Swedbank initiated with a Neutral at Credit Suisse
10/05/20 UBS
Swedbank price target lowered to SEK 172 from SEK 174 at UBS
Recommendations
St. James's Place price target raised to 1,028 GBp at Morgan Stanley » 11:40
10/21/20
10/21
11:40
10/21/20
11:40
STJPF

St. James's Place

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STJPF St. James's Place
$0.00 /

+ (+0.00%)

10/19/20 Barclays
St. James's Place downgraded to Equal Weight from Overweight at Barclays
10/07/20 Barclays
St. James's Place price target raised to 1,224 GBp from 1,182 GBp at Barclays
09/08/20 Barclays
St. James's Place price target raised to 1,182 GBp from 1,104 GBp at Barclays
09/08/20 Berenberg
St. James's Place upgraded to Buy from Hold at Berenberg
Options
Long-dated call buyer takes a $20M ride in Uber » 11:40
10/21/20
10/21
11:40
10/21/20
11:40
UBER

Uber

$35.57 /

-0.74 (-2.04%)

Long-dated call buyer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$35.57 /

-0.74 (-2.04%)

UBER Uber
$35.57 /

-0.74 (-2.04%)

10/09/20 Mizuho
Uber price target raised to $47 from $42 at Mizuho
09/25/20 JPMorgan
Lyft price target lowered to $38 from $41 at JPMorgan
08/28/20 Piper Sandler
Piper 'bearishly inclined' on Uber, Lyft shares into November election
08/24/20 Loop Capital
Uber price target lowered to $40 from $43 at Loop Capital
UBER Uber
$35.57 /

-0.74 (-2.04%)

  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
UBER Uber
$35.57 /

-0.74 (-2.04%)

UBER Uber
$35.57 /

-0.74 (-2.04%)

UBER Uber
$35.57 /

-0.74 (-2.04%)

Hot Stocks
Moody's acquires Neviga's Acquire Media division » 11:36
10/21/20
10/21
11:36
10/21/20
11:36
MCO

Moody's

$282.50 /

-2.83 (-0.99%)

Naviga, provider of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCO Moody's
$282.50 /

-2.83 (-0.99%)

MCO Moody's
$282.50 /

-2.83 (-0.99%)

07/08/20 Goldman Sachs
Moody's price target raised to $295 from $258 at Goldman Sachs
06/08/20 BMO Capital
Moody's price target raised to $298 from $285 at BMO Capital
05/29/20 Credit Suisse
Moody's initiated with an Outperform at Credit Suisse
05/18/20 Oppenheimer
Moody's initiated with an Outperform at Oppenheimer
MCO Moody's
$282.50 /

-2.83 (-0.99%)

MCO Moody's
$282.50 /

-2.83 (-0.99%)

Options
Anheuser Busch put volume heavy and directionally bearish » 11:35
10/21/20
10/21
11:35
10/21/20
11:35
BUD

AB InBev

$55.63 /

-1.28 (-2.25%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$55.63 /

-1.28 (-2.25%)

BUD AB InBev
$55.63 /

-1.28 (-2.25%)

10/15/20
Fly Intel: Pre-market Movers
10/15/20 BofA
AB InBev reinstated with a Neutral at BofA
10/09/20 Morgan Stanley
AB InBev price target raised to EUR 44 from EUR 42 at Morgan Stanley
10/07/20 Jefferies
AB InBev upgraded to Buy from Hold at Jefferies
BUD AB InBev
$55.63 /

-1.28 (-2.25%)

BUD AB InBev
$55.63 /

-1.28 (-2.25%)

BUD AB InBev
$55.63 /

-1.28 (-2.25%)

BUD AB InBev
$55.63 /

-1.28 (-2.25%)

Hot Stocks
Endurance jumps 5% after new report of exploring alternatives » 11:30
10/21/20
10/21
11:30
10/21/20
11:30
EIGI

Endurance

$5.98 /

+0.19 (+3.28%)

Shares of Endurance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIGI Endurance
$5.98 /

+0.19 (+3.28%)

EIGI Endurance
$5.98 /

+0.19 (+3.28%)

EIGI Endurance
$5.98 /

+0.19 (+3.28%)

EIGI Endurance
$5.98 /

+0.19 (+3.28%)

Conference/Events
Avino Silver & Gold participates in a conference call with Cantor Fitzgerald » 11:30
10/21/20
10/21
11:30
10/21/20
11:30
ASM

Avino Silver & Gold Mines

$1.04 /

+0.02 (+1.96%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASM Avino Silver & Gold Mines
$1.04 /

+0.02 (+1.96%)

ASM Avino Silver & Gold Mines
$1.04 /

+0.02 (+1.96%)

10/08/20 Alliance Global Partners
Avino Silver & Gold Mines transferred with a Buy at Alliance Global Partners
08/14/20 Roth Capital
Avino Silver & Gold price target raised to $1.60 from $1.40 at Roth Capital
Conference/Events
Adverum Biotechnologies participates in a conference call with Cantor Fitzgerald » 11:27
10/21/20
10/21
11:27
10/21/20
11:27
ADVM

Adverum Biotechnologies

$11.49 /

-0.18 (-1.54%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$11.49 /

-0.18 (-1.54%)

ADVM Adverum Biotechnologies
$11.49 /

-0.18 (-1.54%)

08/10/20 Piper Sandler
Adverum Biotechnologies price target raised to $30 from $25 at Piper Sandler
07/08/20 Cantor Fitzgerald
Adverum Biotechnologies price target raised to $36 from $21 at Cantor Fitzgerald
06/29/20 Piper Sandler
Adverum Biotechnologies should be bought on selloff, says Piper Sandler
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
ADVM Adverum Biotechnologies
$11.49 /

-0.18 (-1.54%)

  • 13
    Aug
  • 12
    Feb
ADVM Adverum Biotechnologies
$11.49 /

-0.18 (-1.54%)

Syndicate
Supernova Partners Acquisition opens at $10.08, IPO priced at $10 » 11:26
10/21/20
10/21
11:26
10/21/20
11:26
SPNV

Supernova Partners Acquisition

$0.00 /

+ (+0.00%)

Supernova Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.